PIA
DPLO

Piedmont Investment Advisors’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History

Piedmont Investment Advisors’s Portfolio DPLO Stock Details DPLO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-14,874
Closed -$86K – 1362
2019
Q1 		$86K Buy
14,874
+1,403
+10% +$14.5K ﹤0.01% 1133
2018
Q4 		$181K Buy
13,471
+447
+3% +$7.54K 0.01% 954
2018
Q3 		$253K Buy
13,024
+1,646
+14% +$35K 0.01% 862
2018
Q2 		$291K Buy
11,378
+1,088
+11% +$25.4K 0.01% 650
2018
Q1 		$207K Buy
+10,290
New +$240K 0.01% 701
2017
Q4 		– Sell
-10,414
Closed -$216K – 815
2017
Q3 		$216K Buy
+10,414
New +$176K ﹤0.01% 703

Other funds holding DPLO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
SI
Stephens Inc Little Rock, Arkansas $7.99B AUM 21.6% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Piedmont Investment Advisors's DPLO Position: Q2 2019 in Review

Piedmont Investment Advisors sold out of DIPLOMAT PHARMACY, INC. (DPLO) in Q2 2019, closing a stake of 14,874 shares — an estimated $86K sold.

Piedmont Investment Advisors first reported a position in DPLO in Q3 2017 and held it in 6 quarters. The position peaked at $291K in Q2 2018. 131 funds tracked by Wall St. Rank hold DPLO as of Q2 2019.

  • Piedmont Investment Advisors reported no remaining DIPLOMAT PHARMACY, INC. position as of Q2 2019 after selling out during the quarter.
  • Piedmont Investment Advisors sold 14,874 DIPLOMAT PHARMACY, INC. shares in Q2 2019, an estimated $86K.
  • Piedmont Investment Advisors first reported a position in DIPLOMAT PHARMACY, INC. in Q3 2017 and held it in 6 quarters.
  • Piedmont Investment Advisors's DIPLOMAT PHARMACY, INC. position peaked at $291K in Q2 2018.
  • 131 funds tracked by Wall St. Rank held DIPLOMAT PHARMACY, INC. as of Q2 2019.

Based on Piedmont Investment Advisors's 13F filing for Q2 2019, filed 14 Aug 2019.